Baxion
Screening
Tags
Alerts
Theme
Xortx Therapeutics Inc.
XRTX
·
NASDAQ
·
$2.37
Share Price as of 11/2
·
$660,019
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
20-F
Annual report (foreign)
03/20/26
20-F
Annual report (foreign)
05/12/25
20-F
Annual report (foreign)
05/10/24
20-F
Annual report (foreign)
04/28/23
20-F/A
Annual report (foreign, amended)
01/27/23
Disclosures
Filter
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
09/18/26
6-K
Foreign issuer report
09/10/26
6-K
Foreign issuer report
09/09/26
6-K
Foreign issuer report
09/04/26
Prospectuses and Registrations
Filter
424B4
Prospectus
05/15/26
POS AM
Post-effective amendment
05/08/26
POS AM
Post-effective amendment
04/23/26
POS AM
Post-effective amendment
04/22/26
F-1/A
Registration (foreign issuer, amended)
02/13/26
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G
Beneficial ownership
10/27/25
SC 13G/A
Beneficial ownership (amended)
05/15/25
SC 13G
Beneficial ownership
02/14/25
SC 13G/A
Beneficial ownership (amended)
02/14/24
SC 13G
Beneficial ownership
02/14/23
Other
Filter
EFFECT
Request for effectiveness
05/13/26
EFFECT
Request for effectiveness
02/17/26
CORRESP
Correspondence with the SEC
02/12/26
UPLOAD
Letter from the SEC
08/05/25
DRS
DRS
07/30/25
Latest Filings
Filter
6-K
Foreign issuer report
10/08/26
6-K
Foreign issuer report
09/18/26
6-K
Foreign issuer report
09/10/26
6-K
Foreign issuer report
09/09/26
6-K
Foreign issuer report
09/04/26
Ownership
Filter
SC 13G
Beneficial ownership
10/27/25
SC 13G/A
Beneficial ownership (amended)
05/15/25
SC 13G
Beneficial ownership
02/14/25
SC 13G/A
Beneficial ownership (amended)
02/14/24
SC 13G
Beneficial ownership
02/14/23